How Does Kogenate Work? A Deep Dive into Recombinant Factor VIII for Hemophilia A
•
3 min read
Hemophilia A is a genetic bleeding disorder that affects approximately 1 in 5,000 male births and is caused by a deficiency of clotting factor VIII. The medication **Kogenate**, a brand of recombinant Factor VIII, works by temporarily replacing this missing protein, restoring the blood's ability to clot effectively and enabling the control and prevention of bleeds.
